Cosmo First Limited, a diversified player known for its films business, specialty chemicals, and even petcare, just rolled out its Q1 FY26 earnings, and the numbers are certainly eye-catching. In a quarter where the broader market saw a correction and cautious guidance, Cosmo First seems to be charting its own course. The big question is: are these results a flash in the pan, or do they signal a robust growth trajectory ahead, especially as the company doubles down on strategic investments? Let’s peel back the layers.
Did Cosmo First manage to translate its strategic investments into tangible top-line growth this quarter? Absolutely. The company reported a consolidated net sales of INR 800 Cr in Q1 FY26. This represents a healthy 15.9% increase both year-over-year (YoY) and quarter-over-quarter (QoQ), an impressive feat given the general market sentiment.
Here’s a quick look at the sales trend:
Particulars | Unaudited Q1 FY 25-26 Consolidated | Audited Q4 FY 24-25 Consolidated | Unaudited Q1 FY 24-25 Consolidated |
---|---|---|---|
Net Sales | 800 | 746 | 690 |
The primary driver behind this uptick, as highlighted by management, was a 19% higher volume. This is a critical indicator of demand and effective capacity utilization. While the exact split between volume and price growth isn’t detailed, the “improved margins in BOPP films” suggests that price realization played a role too, alongside cost optimization. This combination of volume and price growth is precisely what indicates good sales performance for a company aiming for sustained growth.
The strategic shift towards specialty and semi-specialty films also continues to bolster sales, fetching better realizations compared to commodity films. More on that in the next section.
Cosmo First’s strategic pivot towards high-margin specialty and semi-specialty films is clearly yielding results. While the overall “Specialty & Semi-Speciality Volume (%)” saw a slight dip to 68% in Q1 FY26 from 71% in FY25, it’s important to note that the new BOPP line started commercial production only in June 2025. This new line significantly boosts capacity by approximately 45% and is expected to contribute meaningfully in the coming quarters.
Let’s look at the margin picture for their core BOPP films:
BOPP Quarterly Films Margins (approx. Gross Margin/Kg)
Metric | Q1’FY25 | Q2’FY25 | Q3’FY25 | Q4’FY25 | Q1’FY26 |
---|---|---|---|---|---|
Commodity Margins | ~40 | ~45 | ~45 | ~40 | ~45 |
Semi-Speciality Margins | ~55 | ~60 | ~55 | ~60 | ~60 |
Speciality Margins | ~60 | ~65 | ~65 | ~65 | ~65 |
The consistent and healthy gross margins, especially for specialty films, underline the company’s focus on value-added products. The increase in commodity margins from Q4 FY25 to Q1 FY26 is also a positive sign. The new BOPP line, being highly cost-efficient, should further enhance competitiveness and profitability going forward.
Beyond films, Cosmo First’s diversification strategy is also showing promising signs:
These diverse growth engines, coupled with the core films business, position Cosmo First as a company with multiple avenues for future P&L impact.
The strong sales and improved margins translated directly into a remarkable earnings performance. Consolidated EBITDA for Q1 FY26 surged to INR 116 Cr, a substantial 38.1% jump YoY and 36.5% QoQ. The EBITDA margin expanded impressively to 15% from 11% QoQ and 12% YoY.
Here’s the earnings snapshot:
Particulars | Unaudited Q1 FY 25-26 Consolidated | Audited Q4 FY 24-25 Consolidated | Unaudited Q1 FY 24-25 Consolidated |
---|---|---|---|
EBITDA | 116 | 85 | 84 |
EBITDA % | 15% | 11% | 12% |
PAT | 43 | 27 | 31 |
This robust earnings growth was fueled by:
Given the significant jump in both top-line and bottom-line figures, and the strategic investments clearly beginning to bear fruit, Cosmo First is demonstrating characteristics of a fast grower. After a couple of muted years (FY23-24 saw some dips in annual EBITDA), Q1 FY26 marks a strong turnaround, suggesting the company is back on an aggressive growth path. The focus on cost management alongside revenue growth is exactly what we like to see in a “good earnings” report.
The company’s net debt saw a significant increase, rising to INR 967 Cr in March 2025 from INR 561 Cr in March 2024. While an increase in debt usually warrants scrutiny, management has clearly articulated that this rise is “primarily for enhancing BOPP, CPP and BOPET capacity.” This directly links the debt to growth-oriented capital expenditure.
The new BOPP line, which commenced operations in June 2025, is a direct result of this CapEx, adding 45% to their BOPP capacity. Other investments in CPP, Window, and PPF films over the past three years have also started commercial production. This is crucial: the gestation periods for these investments are ending, and they are now moving from being a drain on cash to contributing to revenue and earnings. This proactive investment aligns well with the domestic-growth themes currently favored in the Indian market, particularly benefiting from the ongoing capex revival and government push for manufacturing.
The key takeaway here is that the financing decisions appear to be strategic, aimed at increasing scale and diversifying revenue streams. The challenge will be to ensure these new capacities are fully utilized and generate returns commensurate with the increased debt.
Cosmo First’s performance aligns well with the prevailing trends in the Indian economy. With projected GDP growth of 6.5-7% for FY26 driven by strong domestic demand, companies focused on home-grown consumption and infrastructure-led cyclicals are poised for success. Cosmo First, with its packaging films serving FMCG, and its new ventures like window films and petcare tapping into discretionary spending, fits this narrative perfectly.
While FPI flows have been volatile, India’s domestic growth story remains compelling. Cosmo First’s strategic investments are aimed at capturing this domestic demand, making it a potentially attractive “domestic-growth theme” stock. Furthermore, their initiatives in renewable energy (targeting INR 20-25 Cr annual power cost savings) demonstrate smart cost management, aligning with broader economic prudence.
Cosmo First has articulated a strategic focus for FY26: fully capitalize on recent investments, increase specialty film sales, and reduce operational costs across all segments to drive profitable growth. Their ambitious target of 20% CAGR topline growth over the next three years, driven by diversified businesses, now seems more achievable given the strong Q1 performance.
The new capacities are online, the specialty chemical business is flying high, and new ventures like Sunshield are gaining traction. While the increase in debt warrants continued monitoring, the underlying operational strength and strategic clarity from management suggest a positive trajectory. Investors will be keenly watching how quickly the new capacities scale up and contribute to the bottom line in the coming quarters. Cosmo First appears to be making a strong case for itself as a revitalized, fast-growing entity poised to capture India’s domestic consumption story.